Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001012870-03-001503
Filing Date
2003-03-31
Accepted
2003-03-31 14:52:13
Documents
12
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED 12/31/2002 d10k.htm 10-K 1138160
3 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLAN, AS AMENDED dex103.txt EX-10.3 23142
4 2000 EQUITY INCENTIVE PLAN, AS AMENDED dex1040.txt EX-10.40 38256
5 2000 NONSTATUTORY INCENTIVE PLAN, AS AMENDED dex1049.txt EX-10.49 32740
6 AMENDED AND RESTATED EXECUTIVE SEVERANCE, LOUIS G. LANGE dex1055.txt EX-10.55 37959
7 AMENDED AND RESTATED EXECUTIVE SEVERANCE, BRENT K. BLACKBURN dex1056.txt EX-10.56 37908
8 AMENDED AND RESTATED EXECUTIVE SEVERANCE, RICHARD M. LAWN dex1057.txt EX-10.57 31818
9 AMENDED AND RESTATED EXECUTIVE SEVERANCE, DANIEL K. SPIEGELMAN dex1058.txt EX-10.58 37958
10 AMENDED AND RESTATED EXECUTIVE SEVERANCE, TRICIA BORGA SUVARI dex1059.txt EX-10.59 32261
11 AMENDED AND RESTATED EXECUTIVE SEVERANCE, ANDREW A. WOLFF dex1060.txt EX-10.60 38536
12 CV THERAPEUTICS, INC. CHANGE IN CONTROL PLAN dex1061.txt EX-10.61 43823
13 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 2680
  Complete submission text file 0001012870-03-001503.txt   1498434
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21643 | Film No.: 03629475
SIC: 2836 Biological Products, (No Diagnostic Substances)